Brief: Equillium Posts Q3 Loss Per Share Of $0.35

Equillium

10/11/2021 21:36

Nov 10 (Reuters) - Equillium Inc  EQ.O :
    * EQUILLIUM REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS AND
PROVIDES CLINICAL DEVELOPMENT UPDATES
    * Q3 LOSS PER SHARE $0.35
    * REAFFIRMS GUIDANCE FOR EQUIP PHASE 1B TOPLINE DATA IN Q4
2021
    * UPDATES GUIDANCE TO COMMENCE ACUTE GVHD PIVOTAL STUDY IN
EARLY
2022
    * UPDATES GUIDANCE FOR INTERIM DATA FROM EQUALISE PHASE 1B
TYPE B
LUPUS NEPHRITIS PATIENTS TO MID-2022
    * BELIEVES THAT ITS CASH AND INVESTMENTS WILL BE SUFFICIENT
TO
FUND ITS CURRENTLY PLANNED OPERATIONS INTO 2023
    * Q3 EARNINGS PER SHARE VIEW $-0.34 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw9lpTJ0a 
Further company coverage:  EQ.O 

 ((Reuters.Briefs@thomsonreuters.com;))